Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 867 M894 M795 M882 M861 M 3.43 B Research & development 143 M159 M166 M161 M163 M 649 M Operating income 276 M444 M619 M474 M-950 M 587 M Non-Operating Income, Total 7 M-17 M8 M-2 M-1 M -12 M Interest expense, net of interest capitalized 330 M465 M412 M397 M402 M 1.68 B Non-Operating Income, excl. Interest Expenses -323 M-482 M-404 M-397 M-403 M -1.69 B Unusual income/expense ———-2 M— — Pretax income -47 M140 M218 M56 M-1.35 B -940 M Equity in earnings ————— — Taxes 39 M12 M37 M159 M77 M 285 M Non-controlling/minority interest -28 M-20 M2 M9 M-8 M -17 M After tax other income/expense ————— — Net income before discontinued operations -58 M148 M179 M-112 M-1.42 B -1.21 B Discontinued operations ————— — Net income -58 M148 M179 M-112 M-1.42 B -1.21 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -58 M148 M179 M-112 M-1.42 B -1.21 B Basic earnings per share (Basic EPS) -0.160.40.48-0.3-3.82 -3.24 Diluted earnings per share (Diluted EPS) -0.160.40.48-0.3-3.82 -3.24 Average basic shares outstanding 369.6 M370.9 M371.3 M370.9 M372.8 M — Diluted shares outstanding 369.6 M373.1 M375.5 M375 M372.8 M — EBITDA 291 M485 M635 M496 M-936 M 680 M EBIT 276 M444 M619 M474 M-950 M 587 M Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) 15 M41 M16 M22 M14 M 93 M